Table 1.

Frequency of symptoms and co-morbidities in the total sample and in those testing positive for current or past infection with severe acute respiratory syndrome coronavirus 2 in Louisiana

	Number reporting		Any positive test		Prevalence by factora
	n = 4778		n = 311 (6.5%)
	n	%	n	%	%
New Orleans (May 2020)	2640	55.3%	183	58.8%	6.9%
Baton Rouge (July 2020)	2138	44.7%	128	41.2%	6.0%
Any symptoms	1223	25.6%	164	52.7%	13.4%
Fever	471	9.9%	84	27.0%	17.8%
Fatigue	658	13.8%	95	30.5%	14.4%
Dry cough	568	11.9%	82	26.4%	14.4%
Myalgia	519	10.9%	83	26.7%	16.0%
Nasal congestion	456	9.5%	68	21.9%	14.9%
Runny nose	327	6.8%	45	14.5%	13.8%
Sore throat	488	10.2%	60	19.3%	12.3%
Diarrhoea	245	5.1%	33	10.6%	13.5%
Anosmia/dysgeusia	229	4.8%	93	29.9%	40.6%
Chills	337	7.1%	54	17.4%	16.0%
Headache	522	10.9%	74	23.8%	14.2%
Other	194	4.1%	16	5.1%	8.2%
No symptoms	3555	74.4%	147	47.3%	4.1%
Any co-morbidities	2167	45.4%	139	44.7%	6.4%
Diabetes	444	9.3%	30	9.6%	6.8%
High blood pressure	1367	28.6%	90	28.9%	6.6%
Elevated cholesterol	797	16.7%	53	17.0%	6.6%
Heart disease	170	3.6%	12	3.9%	7.1%
Kidney disease	51	1.1%	6	1.9%	11.8%
COPD	50	1.0%	3	1.0%	6.0%
History of cancer	318	6.7%	13	4.2%	4.1%
HIV	23	0.5%	0	0.0%	0.0%
Organ Tx	19	0.4%	1	0.3%	5.3%
Weakened immune system	155	3.2%	9	2.9%	5.8%
Other	216	4.5%	9	2.9%	4.2%
No co-morbidities	2611	54.6%	172	55.3%	6.6%

Abbreviations: COPD, chronic obstructive pulmonary disease; HIV, human immunodeficiency virus; Tx, transplant.

^aPrevalence by factor is calculated by dividing the number of positives over the total number in the sample reporting that factor.